SavedAdd your journal

Journals / ENT Updates / 2015 / Cilt: 5 - Sayı: 2

Sinonazal Sonuç Testinin (SNOT-22) Türkçeye çevirisi, kültürler arası adaptasyonu ve validasyonu

Turkish translation, cross-cultural adaptation and validation of the SinoNasal Outcome Test (SNOT)-22

Deniz HANCI
HÜSEYİN ALTUN
Ethem ŞAHİN
Niyazi ALTINTOPRAK
CEMAL CİNGİ
Pages
51–57
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results indicated that the Turkish version of the SNOT-22 is a valid instrument with good internal consistency, excellent reproducibility, validity, and responsiveness for assessing patients with CRS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this prospective case-control study, we aimed to perform translation, cross-cultural adaptation, and validation of the SinoNasal Outcome Test (SNOT)-22 in the Turkish language.
📊
Key Findings & Data:Methods: Validation of the Turkish questionnaire included translation of original SNOT-22 items from English to Turkish by two independent native Turkish translators, and retranslation back from Turkish to English by two other native English translators.
💡
Conclusion & Impact:Conclusion: The results indicated that the Turkish version of the SNOT-22 is a valid instrument with good internal consistency, excellent reproducibility, validity, and responsiveness for assessing patients with CRS.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this prospective case-control study, we aimed to perform translation, cross-cultural adaptation, and validation of the SinoNasal Outcome Test (SNOT)-22 in the Turkish language. Methods: Validation of the Turkish questionnaire included translation of original SNOT-22 items from English to Turkish by two independent native Turkish translators, and retranslation back from Turkish to English by two other native English translators. The test-retest reliability was carried out in patients with chronic rhinosinusitis (CRS). SNOT-22 questionnaire was applied twice by two different physicians. Results: Cronbach's alpha was 0.88 and 0.90 at test and retest examinations, respectively, suggesting good internal consistency within the SNOT-22 questionnaire. Pearson's correlation coefficient was 0.97, revealing excellent correlation in repeated examinations. Mean of kappa values evaluated for individual items was 0.83, indicating a high level of reproducibility. The comparison of mean SNOT-22 scores of healthy individuals with those of patient group indicated statistically significant difference between the two groups, proving the validity of SNOT-22 in Turkish in differentiating between healthy individuals and patients with CRS. The statistically significant reduction in the postoperative and preoperative mean SNOT-22 scores demonstrated the responsiveness of the instrument. Conclusion: The results indicated that the Turkish version of the SNOT-22 is a valid instrument with good internal consistency, excellent reproducibility, validity, and responsiveness for assessing patients with CRS.

Özet

Amaç: Bu prospektif olgu-kontrollü çalışmada Sinonazal Sonuç Testinin (SNOT-22) Türkçeye çevirisi, kültürler arası adaptasyonu ve validasyonunu gerçekleştirmeyi amaçladık. Yöntem: Türkçe anketin validasyonu orijinal SNOT-22 maddelerinin anadili Türkçe olan, birbirlerinden bağımsız iki çevirmen tarafından İngilizceden Türkçeye, daha sonra anadili İngilizce olan başka iki çevirmen tarafından yeniden Türkçeden İngilizceye çevrilmesini içermiştir. Kronik rinosinüziti (KRS) olan hastalarda test-yeniden test güvenilirliği işlemi gerçekleştirilmiştir. İki ayrı doktor SNOT-22 anketini iki kez uygulamıştır. Bulgular: Test ve yeniden test etme süreçlerinde Cronbach alfa katsayılarının sırasıyla 0.88 ve 0.90 olması SNOT-22 anketinin iyi bir iç tutarlılığa sahip olduğunu düşündürmektedir. Pearson korelasyon katsayısının 0.97 olması yinelenen muayenelerde mükemmel bir korelasyonun varlığını ortaya çıkartmıştır. Tek tek maddeler için hesaplanan kappa değerleri ortalamasının 0.83 olması yüksek bir tekrarlanabilirlik düzeyini göstermektedir. Sağlıklı kişilerin ortalama SNOT-22 skorlarının hasta grubuyla karşılaştırması iki grup arasında istatistiksel açıdan anlamlı farklılık olduğunu göstererek sağlıklı bireylerle, KRS'si olan hastaların ayrımında Türkçe SNOT-22'nin geçerliliğini kanıtlamıştır. Postoperatif ve preoperatif ortalama SNOT-22 skorlarındaki istatistiksel açıdan anlamlı azalma bu aracın duyarlı olduğunu göstermiştir. Sonuç: Sonuçlar SNOT-22'nin Türkçe versiyonunun iyi bir iç tutarlılık, mükemmel bir tekrarlanabilirlik, validite ve KRS hastalarını değerlendirmede duyarlılığa (yanıt verilebilirliğe) sahip olduğuna işaret etmiştir.

🔖

Cite This Article

HANCI, D., ALTUN, H., ŞAHİN, E., ALTINTOPRAK, N., CİNGİ, C. (2015). Sinonazal Sonuç Testinin (SNOT-22) Türkçeye çevirisi, kültürler arası adaptasyonu ve validasyonu. ENT Updates, Cilt: 5 - Sayı: 2, 51–57. https://ajindex.com/articles/154537

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Meltzer EO, Hamilos DL, Hadley JA, et al.; American Academy of Allergy, Asthma and Immunology; American Academy of Otolaryngic Allergy; American Academy of Otolaryngology-Head and Neck Surgery; American College of Allergy, Asthma and Immunology; American Rhinologic Society. Rhinosinusitis: estab- lishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004;131(6 Suppl):S1–62
  2. Lange B, Thilsing T, Al-kalemji A, Baelum J, Martinussen T, Kjeldsen A. The Sino-Nasal Outcome Test 22 validated for Danish patients. Dan Med Bull 2011;58:A4235
  3. Marambaia PP, Lima MG, Santos KP, Gomes Ade M, de Sousa MM, Marques ME. Evaluation of the quality of life of patients with chronic rhinosinusitis by means of the SNOT-22 question- naire. Braz J Otorhinolaryngol 2013;79:54–8
  4. Lachanas VA, Tsea M, Tsiouvaka S, Hajiioannou JK, Skoulakis CE, Bizakis J G. The sino-nasal outcome test (SNOT)-22: valida- tion for Greek patients. Eur Arch Otorhinolaryngol 2014;271: 2723–8. 5. de Dorlodot C, Horoi M, Lefebvre P, et al. French adaptation and validation of the sino-nasal outcome test-22: a prospective cohort study on quality of life among 422 subjects. Clin Otolaryngol 2015;40:29–35
  5. Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe – an underestimated disease. A GAÇLEN study. Allergy 2011;66:1216–23
  6. Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10 2012;(260):1–161
  7. Vaitkus S, Padervinskis E, Balsevicius T, et al. Translation, cross- cultural adaptation, and validation of the sino-nasal outcome test (SNOT)-22 for Lithuanian patients. Eur Arch Otorhinolaryngol 2013;270:1843–8
  8. Abdalla S, Alreefy H, Hopkins C. Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit. Clin Otolaryngol 2012;37:276–82
  9. Schalek P, Otruba L, Hahn A. Quality of life in patients with chronic rhinosinusitis: a validation of the Czech version of SNOT-22 questionnaire. Eur Arch Otorhinolaryngol 2010;267: 473–5
  10. Kosugi EM, Chen VG, Fonseca VM, Cursino MM, Mendes Neto JA, Gregório LC. Translation, cross-cultural adaptation and vali- dation of SinoNasal Outcome Test (SNOT): 22 to Brazilian Portuguese. Braz J Otorhinolaryngol 2011;77:663–9
  11. Caminha GP, Melo Junior JT, Hopkins C, Pizzichini E, Pizzichini MM. SNOT-22: psychometric prop